Cipla's revenue share 2023, by medical therapy
Cipla Limited in India has been known for its generic drugs, of which the respiratory drugs made up the largest share of its total revenue with 38.9 percent of contribution in fiscal year 2023. This was followed by the company's anti-infective drugs and cardiac drugs with about 15 and 11 percent share of the revenue respectively.
